 | • レポートコード：GIR-107A15087 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ルフィナミドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ルフィナミドの種類別市場規模（錠剤、経口懸濁液）、用途別市場規模（成人、小児患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ルフィナミドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eisai、Glenmark Pharms、Mylan、West-ward Pharms ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、経口懸濁液 ・用途別分析2016年-2026年：成人、小児患者 ・ルフィナミドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ルフィナミドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ルフィナミドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ルフィナミドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ルフィナミドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rufinamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rufinamide size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Rufinamide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rufinamide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Oral suspension
Market segment by Application, can be divided into
Adults
Pediatric patients
Market segment by players, this report covers
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Rufinamide
1.2 Classification of Rufinamide by Type
1.2.1 Overview: Global Rufinamide Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Rufinamide Revenue Market Share by Type in 2020
1.2.3 Tablets
1.2.4 Oral suspension
1.3 Global Rufinamide Market by Application
1.3.1 Overview: Global Rufinamide Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Rufinamide Market Size & Forecast
1.5 Global Rufinamide Market Size and Forecast by Region
1.5.1 Global Rufinamide Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Rufinamide Market Size by Region, (2016-2021)
1.5.3 North America Rufinamide Market Size and Prospect (2016-2026)
1.5.4 Europe Rufinamide Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Rufinamide Market Size and Prospect (2016-2026)
1.5.6 South America Rufinamide Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Rufinamide Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Rufinamide Market Drivers
1.6.2 Rufinamide Market Restraints
1.6.3 Rufinamide Trends Analysis
2 Company Profiles
2.1 Eisai
2.1.1 Eisai Details
2.1.2 Eisai Major Business
2.1.3 Eisai Rufinamide Product and Solutions
2.1.4 Eisai Rufinamide Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eisai Recent Developments and Future Plans
2.2 Glenmark Pharms
2.2.1 Glenmark Pharms Details
2.2.2 Glenmark Pharms Major Business
2.2.3 Glenmark Pharms Rufinamide Product and Solutions
2.2.4 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Glenmark Pharms Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Rufinamide Product and Solutions
2.3.4 Mylan Rufinamide Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mylan Recent Developments and Future Plans
2.4 West-ward Pharms
2.4.1 West-ward Pharms Details
2.4.2 West-ward Pharms Major Business
2.4.3 West-ward Pharms Rufinamide Product and Solutions
2.4.4 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 West-ward Pharms Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Rufinamide Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Rufinamide Players Market Share
3.2.2 Top 10 Rufinamide Players Market Share
3.2.3 Market Competition Trend
3.3 Rufinamide Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Rufinamide Revenue and Market Share by Type (2016-2021)
4.2 Global Rufinamide Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Rufinamide Revenue Market Share by Application (2016-2021)
5.2 Rufinamide Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Rufinamide Revenue by Type (2016-2026)
6.2 North America Rufinamide Revenue by Application (2016-2026)
6.3 North America Rufinamide Market Size by Country
6.3.1 North America Rufinamide Revenue by Country (2016-2026)
6.3.2 United States Rufinamide Market Size and Forecast (2016-2026)
6.3.3 Canada Rufinamide Market Size and Forecast (2016-2026)
6.3.4 Mexico Rufinamide Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Rufinamide Revenue by Type (2016-2026)
7.2 Europe Rufinamide Revenue by Application (2016-2026)
7.3 Europe Rufinamide Market Size by Country
7.3.1 Europe Rufinamide Revenue by Country (2016-2026)
7.3.2 Germany Rufinamide Market Size and Forecast (2016-2026)
7.3.3 France Rufinamide Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Rufinamide Market Size and Forecast (2016-2026)
7.3.5 Russia Rufinamide Market Size and Forecast (2016-2026)
7.3.6 Italy Rufinamide Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Rufinamide Revenue by Type (2016-2026)
8.2 Asia-Pacific Rufinamide Revenue by Application (2016-2026)
8.3 Asia-Pacific Rufinamide Market Size by Region
8.3.1 Asia-Pacific Rufinamide Revenue by Region (2016-2026)
8.3.2 China Rufinamide Market Size and Forecast (2016-2026)
8.3.3 Japan Rufinamide Market Size and Forecast (2016-2026)
8.3.4 South Korea Rufinamide Market Size and Forecast (2016-2026)
8.3.5 India Rufinamide Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Rufinamide Market Size and Forecast (2016-2026)
8.3.7 Australia Rufinamide Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Rufinamide Revenue by Type (2016-2026)
9.2 South America Rufinamide Revenue by Application (2016-2026)
9.3 South America Rufinamide Market Size by Country
9.3.1 South America Rufinamide Revenue by Country (2016-2026)
9.3.2 Brazil Rufinamide Market Size and Forecast (2016-2026)
9.3.3 Argentina Rufinamide Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Rufinamide Revenue by Type (2016-2026)
10.2 Middle East & Africa Rufinamide Revenue by Application (2016-2026)
10.3 Middle East & Africa Rufinamide Market Size by Country
10.3.1 Middle East & Africa Rufinamide Revenue by Country (2016-2026)
10.3.2 Turkey Rufinamide Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Rufinamide Market Size and Forecast (2016-2026)
10.3.4 UAE Rufinamide Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Rufinamide Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Rufinamide Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Rufinamide Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Rufinamide Revenue (USD Million) by Region (2016-2021)
Table 5. Global Rufinamide Revenue Market Share by Region (2021-2026)
Table 6. Eisai Corporate Information, Head Office, and Major Competitors
Table 7. Eisai Major Business
Table 8. Eisai Rufinamide Product and Solutions
Table 9. Eisai Rufinamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Glenmark Pharms Corporate Information, Head Office, and Major Competitors
Table 11. Glenmark Pharms Major Business
Table 12. Glenmark Pharms Rufinamide Product and Solutions
Table 13. Glenmark Pharms Rufinamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mylan Corporate Information, Head Office, and Major Competitors
Table 15. Mylan Major Business
Table 16. Mylan Rufinamide Product and Solutions
Table 17. Mylan Rufinamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. West-ward Pharms Corporate Information, Head Office, and Major Competitors
Table 19. West-ward Pharms Major Business
Table 20. West-ward Pharms Rufinamide Product and Solutions
Table 21. West-ward Pharms Rufinamide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Rufinamide Revenue (USD Million) by Players (2019-2021)
Table 23. Global Rufinamide Revenue Share by Players (2019-2021)
Table 24. Breakdown of Rufinamide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Rufinamide Players Head Office, Products and Services Provided
Table 26. Rufinamide Mergers & Acquisitions in the Past Five Years
Table 27. Rufinamide New Entrants and Expansion Plans
Table 28. Global Rufinamide Revenue (USD Million) by Type (2016-2021)
Table 29. Global Rufinamide Revenue Share by Type (2016-2021)
Table 30. Global Rufinamide Revenue Forecast by Type (2021-2026)
Table 31. Global Rufinamide Revenue by Application (2016-2021)
Table 32. Global Rufinamide Revenue Forecast by Application (2021-2026)
Table 33. North America Rufinamide Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Rufinamide Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Rufinamide Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Rufinamide Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Rufinamide Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Rufinamide Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Rufinamide Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Rufinamide Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Rufinamide Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Rufinamide Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Rufinamide Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Rufinamide Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Rufinamide Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Rufinamide Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Rufinamide Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Rufinamide Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Rufinamide Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Rufinamide Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Rufinamide Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Rufinamide Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Rufinamide Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Rufinamide Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Rufinamide Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Rufinamide Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Rufinamide Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Rufinamide Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Rufinamide Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Rufinamide Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Rufinamide Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Rufinamide Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Rufinamide Picture
Figure 2. Global Rufinamide Revenue Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Oral suspension
Figure 5. Rufinamide Revenue Market Share by Application in 2020
Figure 6. Adults Picture
Figure 7. Pediatric patients Picture
Figure 8. Global Rufinamide Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Rufinamide Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Rufinamide Revenue Market Share by Region (2016-2026)
Figure 11. Global Rufinamide Revenue Market Share by Region in 2020
Figure 12. North America Rufinamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Rufinamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Rufinamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Rufinamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Rufinamide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Rufinamide Market Drivers
Figure 18. Rufinamide Market Restraints
Figure 19. Rufinamide Market Trends
Figure 20. Eisai Recent Developments and Future Plans
Figure 21. Glenmark Pharms Recent Developments and Future Plans
Figure 22. Mylan Recent Developments and Future Plans
Figure 23. West-ward Pharms Recent Developments and Future Plans
Figure 24. Global Rufinamide Revenue Share by Players in 2020
Figure 25. Rufinamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 26. Global Top 3 Players Rufinamide Revenue Market Share in 2020
Figure 27. Global Top 10 Players Rufinamide Revenue Market Share in 2020
Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 29. Global Rufinamide Revenue Share by Type in 2020
Figure 30. Global Rufinamide Market Share Forecast by Type (2021-2026)
Figure 31. Global Rufinamide Revenue Share by Application in 2020
Figure 32. Global Rufinamide Market Share Forecast by Application (2021-2026)
Figure 33. North America Rufinamide Sales Market Share by Type (2016-2026)
Figure 34. North America Rufinamide Sales Market Share by Application (2016-2026)
Figure 35. North America Rufinamide Revenue Market Share by Country (2016-2026)
Figure 36. United States Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Canada Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Mexico Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Europe Rufinamide Sales Market Share by Type (2016-2026)
Figure 40. Europe Rufinamide Sales Market Share by Application (2016-2026)
Figure 41. Europe Rufinamide Revenue Market Share by Country (2016-2026)
Figure 42. Germany Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. France Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. United Kingdom Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Russia Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Italy Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Rufinamide Sales Market Share by Type (2016-2026)
Figure 48. Asia-Pacific Rufinamide Sales Market Share by Application (2016-2026)
Figure 49. Asia-Pacific Rufinamide Revenue Market Share by Region (2016-2026)
Figure 50. China Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Japan Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. South Korea Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. India Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Southeast Asia Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Australia Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South America Rufinamide Sales Market Share by Type (2016-2026)
Figure 57. South America Rufinamide Sales Market Share by Application (2016-2026)
Figure 58. South America Rufinamide Revenue Market Share by Country (2016-2026)
Figure 59. Brazil Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Argentina Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Middle East and Africa Rufinamide Sales Market Share by Type (2016-2026)
Figure 62. Middle East and Africa Rufinamide Sales Market Share by Application (2016-2026)
Figure 63. Middle East and Africa Rufinamide Revenue Market Share by Country (2016-2026)
Figure 64. Turkey Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Saudi Arabia Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. UAE Rufinamide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Methodology
Figure 68. Research Process and Data Source
世界のルフィナミド市場予測（～2024年） Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Scope of the Report: The global Rufinamide market is valued at xx million USD in 2018 and is expected to reach xx million USD …- 世界のエトラビリン市場 2021：企業別、地域別、種類・用途別 The Etravirine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界の小児硝子体切除術市場 2021：企業別、地域別、種類・用途別 The Pediatric Vitrectomy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のラコサミド市場 2021：企業別、地域別、種類・用途別 The Lacosamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- 世界のプレリキサフォル市場 2021：企業別、地域別、種類・用途別 The Plerixafor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …